Healio
Healio
Trial Scorecards Banner Image

Trial Scorecards
Issue: October 2013
October 01, 2013
1 min read
Save

PARIS

Issue: October 2013
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers determined discontinuation, interruption or disruption of dual antiplatelet therapy and whether it was associated with any major adverse CV events.

PARIS

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.